1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and niflumic acid

1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one has been researched along with niflumic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Goyal, RK; He, XD1
Paterson, WG; Zhang, Y1

Other Studies

3 other study(ies) available for 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and niflumic acid

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Evidence for NO. redox form of nitric oxide as nitrergic inhibitory neurotransmitter in gut.
    The American journal of physiology, 1998, Volume: 275, Issue:5

    Topics: Aminoquinolines; Animals; Apamin; Chloride Channels; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Guinea Pigs; Ileum; In Vitro Techniques; Muscle, Smooth; Neuromuscular Junction; Neurotransmitter Agents; Niflumic Acid; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; ortho-Aminobenzoates; Oxadiazoles; Oxidation-Reduction; Potassium Channel Blockers; Quinoxalines

1998
Role of sarcoplasmic reticulum in control of membrane potential and nitrergic response in opossum lower esophageal sphincter.
    British journal of pharmacology, 2003, Volume: 140, Issue:6

    Topics: Animals; Anthracenes; Atropine; Azepines; Caffeine; Calcium; Chloride Channels; Enzyme Inhibitors; Esophagogastric Junction; Female; Guanethidine; In Vitro Techniques; Indoles; Male; Membrane Potentials; Muscle, Smooth; Myosin-Light-Chain Kinase; Nifedipine; Niflumic Acid; Nitric Oxide; Opossums; Oxadiazoles; Quinoxalines; Ryanodine; Sarcoplasmic Reticulum; Substance P; Tetraethylammonium

2003